Urolithiasis Management Devices Market, By Product Type (Shockwave lithotripter (Intracorporeal Lithotripter, Extracorporeal Lithotripter), and Ureterorenoscope (Rigid Ureterorenoscope, Semi Rigid Ureterorenoscope, Flexible Ureterorenoscope)), By End User

Urolithiasis Management Devices Market, By Product Type (Shockwave lithotripter (Intracorporeal Lithotripter, Extracorporeal Lithotripter), and Ureterorenoscope (Rigid Ureterorenoscope, Semi Rigid Ureterorenoscope, Flexible Ureterorenoscope)), By End Users (Hospitals, Clinics, Ambulatory Surgical Centers), And by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)- Size, Share, Outlook, and Opportunity Analysis, 2023 - 2030

Urolithiasis is referred to as kidney stone and is a condition that is characterized by the presence of a calculi or a solid piece of material in the urinary tract of an individual. This solid mass commonly known as a kidney stone is typically formed in the renal area that is eliminated from the body through the urine stream. The most common symptom is severe pain, which usually occurs on the side of the abdomen, that's often associated with nausea. A kidney stone usually will not cause symptoms until it moves around within the kidney or passes into one of the ureters. The ureters are the tubes that connect the kidneys and bladder, one of the most common devices for the treatment of urolithiasis is the shock wave lithotripter, which is the most common treatment for kidney stones, shock waves from outside the body is targeted at a kidney stone. The rising incidence of chronic kidney diseases and increasing healthcare infrastructure in developing economies are major factors responsible for the growth of the global urolithiasis management devices market. Furthermore, major players in the global urolithiasis management devices market are focused on launching new products to expand their product portfolio which is also expected to assist the market growth during the forecast period.

Market Dynamics

Key players in the global urolithiasis management devices market are focused on research and development of the products For instance, according to Springer Nature, a German-British academic publishing company, stated that ongoing research is attempting to improve extracorporeal shockwave lithotripsy (ESWL) in several different ways, which helped improving in shockwave generation, shockwave measurement, and stone localization should result in increasingly efficient lithotripsy. Futher, the application of the time reversal process to lithotripsy will allow lithotriptors to track stones and electronically steer shock waves toward the target automatically. A reduction in cavitary fields which may result in less pain at the time of treatment.

Key features of the study:

• This report provides in-depth analysis of the global urolithiasis management devices market and provides market size (US$ million) and compound annual growth rate (CAGR %) for the forecast period (2023–2030), considering 2022 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategy adopted by key players
• It profiles key players in the global urolithiasis management devices market based on the following parameters – company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
• Key companies covered as a part of this study include Lumenis Be Ltd., Boston Scientific Corp., BD, Cook Medical, Karl Storz, Allengers Medical Systems, Inc., Olympus Corporation, Electro Medical Systems SA, Dornier MedTech GmbH, Direx Group, HealthTronics, Inc., CONMED Corporation., Potent Medical., Applaud Medical, Inc., and other prominent players.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, technology up-gradation, market expansion, and marketing tactics
• The global urolithiasis management devices market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global urolithiasis management devices market

Detailed Segmentation:

• Global Urolithiasis Management Devices Market, By Product Type:
• Shock Wave Lithotripter
• Intracorporeal Lithotripter
• Extracorporeal Lithotripter
• Ureterorenoscope
• Rigid Ureterorenoscopes
• Semi Rigid Ureterorenoscopes
• Flexible Ureterorenoscopes
• Global Urolithiasis Management Devices Market, By End User:
• Hospitals
• Clinics
• Ambulatory Surgical Centers
• Global Urolithiasis Management Devices Market, By Region:
• North America
• By Country:
• U.S.
• Canada
• Latin America
• By Country:
• Brazil
• Mexico
• Argentina
• Rest of Latin America
• Europe
• By Country:
• Germany
• U.K.
• France
• Italy
• Spain
• Russia
• Rest of Europe
• Asia Pacific
• By Country
• China
• India
• Japan
• Australia
• South Korea
• ASEAN
• Rest of Asia Pacific
• Middle East
• By Country:
• GCC
• Israel
• Rest of Middle East
• Africa
• By Country/Region:
• South Africa
• Central Africa
• North Africa
• Company Profiles
• Lumenis Be Ltd.*
• Company Highlights
• Products Portfolio
• Key Highlights
• Financial Performance
• Strategies
• Boston Scientific Corp.
• BD
• Cook Medical
• Karl Storz
• Allengers Medical Systems Inc.
• Olympus Corporation
• Electro Medical Systems SA
• Dornier MedTech GmbH
• Direx Group
• HealthTronics, Inc.
• CONMED Corporation.
• Potent Medical.
• Applaud Medical, Inc.

“*” marked represents similar segmentation in other categories in the respective section.